GenomSys

About:

GenomSys is a Swiss health software company providing solutions for genomic data analyses to accelerate time to market for new applications.

Website: https://www.genomsys.com

Top Investors: EASME - EU Executive Agency for SMEs, Club degli Investitori, Eurostars, Elysian Capital LLP, Dolby Family Ventures

Description:

GenomSys is a Swiss health software company accelerating personalized genomics. As genomic applications are becoming widespread and data volumes are growing, there is a pressing need for data and process efficiency, interoperability, and software robustness. GenomSys offer a unique multi-infrastructure genomic platform, based on the ISO/IEC 23092 genomic standard (MPEG-G, "the MP3 for genomic data") we contributed to shape, enabling fast time-to-market of innovative applications with high potential. GenomSys solutions are cheaper (storage needs -70%), faster (4-month time-to-market of innovative application), interoperable, ready for mobile personal genomics, regulatory conscious.

Total Funding Amount:

$9.45M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lausanne, Vaud, Switzerland

Founded Date:

2016-03-01

Contact Email:

info(AT)genomsys.com

Founders:

Claudio Alberti

Number of Employees:

11-50

Last Funding Date:

2019-09-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai